| Riverside Regional Medical Center | |
| 500 J Clyde Morris Blvd, Newport News, Virginia 23601 | |
| (757) 594-2000 | |
| Name | Riverside Regional Medical Center |
|---|---|
| Type | Acute Care Hospital |
| Location | 500 J Clyde Morris Blvd, Newport News, Virginia |
| Ownership | Voluntary non-profit - Private |
| Emergency Services | Yes |
| Medicare ID (CCN) | 490052 |
| NPI Number | 1073571865 |
| Organization Name | LTACH AT RIVERSIDE, LLC |
| Doing Business As | HAMPTON ROADS SPECIALTY HOSPITAL |
| Address | 500 J Clyde Morris Blvd, 4th Floor East And 4th Floor Annex, Newport News, VA 23601 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 757-928-8261 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1215462775 |
| Organization Name | COASTAL VIRGINIA REHABILITATION, LLC |
| Doing Business As | RIVERSIDE REHABILITATION HOSPITAL |
| Address | 245 Chesapeake Ave, Newport News, VA 23607 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 717-972-1100 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1245765783 |
| Organization Name | LTACH AT RIVERSIDE, LLC |
| Address | 500 J Clyde Morris Blvd, 4th Floor East And 4th Floor Annex, Newport News, VA 23601 |
| Hospital Type | Long Term Care Hospital |
| Phone Number | 717-972-1100 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1356543995 |
| Organization Name | RIVERSIDE REGIONAL MEDICAL CENTER |
| Address | 500 J Clyde Morris Blvd, Department Of Medical Education - Family Medicine, Newport News, VA 23601 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 757-594-2000 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1366547747 |
| Organization Name | RIVERSIDE HOSPITAL INC |
| Doing Business As | RIVERSIDE REGIONAL MEDICAL CENTER |
| Address | 500 J Clyde Morris Blvd, Newport News, VA 23601 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 757-594-2000 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1700088721 |
| Organization Name | RIVERSIDE REGIONAL MEDICAL CENTER |
| Address | 500 J Clyde Morris Blvd, Newport News, VA 23601 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 757-594-2000 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1841424744 |
| Organization Name | RIVERSIDE REGIONAL MEDICAL CENTER |
| Address | 10510 Jefferson Ave. Suid D, Brentwood Ob Gyn, Newport News, VA 23601 |
| Hospital Type | General Acute Care Hospital - Women |
| Phone Number | 757-594-4737 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1861779852 |
| Organization Name | RIVERSIDE REGIONAL MEDICAL CENTER |
| Address | 542 K Eleanor Court, Newport News, VA 23602 |
| Hospital Type | General Acute Care Hospital |
| Phone Number | 757-358-0042 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| NPI Number | 1992814826 |
| Organization Name | REHABILITATION INSTITUTE OF VIRGINIA INC |
| Doing Business As | RIVERSIDE REHABILITATION INSTITUTE |
| Address | 245 Chesapeake Ave, Newport News, VA 23607 |
| Hospital Type | Rehabilitation Hospital |
| Phone Number | 757-928-8000 |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
| Able to receive lab results electronically | Yes |
| Able to track patients' lab results, tests, and referrals electronically between visits | Yes |
News Archive
The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Cambridge, MA-based Torus BiosystemsTM, Inc., will develop and commercialize DNA nanotechnology developed at the Wyss Institute by Peng Yin and David Zhang.
In a study published in the Journal of Bone and Mineral Research, blood tests that detect fragments of a protein secreted by bone cells helped to predict fracture risk in postmenopausal women, independently of bone mineral density, bone turnover markers, and other measures of bone health.
Women with depression may be much more likely than men to get relief from a commonly used, inexpensive antidepressant drug, a new national study finds. But many members of both sexes may find that it helps ease their depression symptoms.
The research, which is led by two University of New South Wales academics, is significant because drugs that are in the advanced developmental phase for other conditions might be able to be used on Alzheimer's patients, to halt the disease progressing.
› Verified 5 days ago
Bon Secours Mary Immaculate Hospital Acute Care Hospital Location: 2 Bernardine Drive, Newport News, Virginia 23602 Phone: (757) 886-6000 | |
Riverside Regional Medical Center Acute Care Hospital Location: 500 J Clyde Morris Blvd, Newport News, Virginia 23601 Phone: (757) 594-2000 |